GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a truly shift in how we approach diabetes mellitus . These new drugs work by mimicking the body’s natural GLP-1 substance , which supports https://seolistlinks.com/story23249775/glp-1-a-revolutionary-advance-in-blood-sugar-treatment